# Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

Study · id `cardio:ct-nct05499832` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05499832](<https://clinicaltrials.gov/study/NCT05499832>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05499832

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.

## Technical summary

Registry record NCT05499832. Randomized; single masking; primary purpose treatment. Start 2023-03-21 (actual); primary completion 2025-10-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 156 participants (enrolled count; ClinicalTrials.gov record NCT05499832, source copy `cardio:ctgov-nct05499832-2026-02-10`, retrieved 2026-10-26)
- Started: 2023-03-21 (actual) (ClinicalTrials.gov record NCT05499832, source copy `cardio:ctgov-nct05499832-2026-02-10`, retrieved 2026-10-26)
- Primary completion: 2025-10-09 (actual) (ClinicalTrials.gov record NCT05499832, source copy `cardio:ctgov-nct05499832-2026-02-10`, retrieved 2026-10-26)
- Completion: 2025-10-09 (actual) (ClinicalTrials.gov record NCT05499832, source copy `cardio:ctgov-nct05499832-2026-02-10`, retrieved 2026-10-26)
- Countries: Austria; Belgium; Finland; Germany; Netherlands; Portugal; Switzerland (ClinicalTrials.gov record NCT05499832, source copy `cardio:ctgov-nct05499832-2026-02-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05499832-2026-02-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions
- Acronym: TECNO
- Condition: Ischemic Stroke
- Intervention (Drug): Tenecteplase
- Lead sponsor: Insel Gruppe AG, University Hospital Bern
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)
- Registry lists this organization as the lead sponsor: Insel Gruppe AG, University Hospital Bern (`cardio:org-insel-gruppe-ag-university-hospital-bern`)

## Provenance

Content hash: 23685726931af865a04fc5efcb6234b6594d9a371e84f100435536d8fee4b3cf
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
